Dr. Mihai Pop is a Professor of Computer Science and Director of the University of Maryland Institute for Advanced Computer Studies (UMIACS). He holds appointments in the Department of Computer Science, UMIACS, and the Center for Bioinformatics and Computational Biology (CBCB). His research focuses on computational biology, metagenomics, and algorithm development for genomic data analysis. He received a Ph.D. in Computer Science from Johns Hopkins University (2000), followed by work at The Institute for Genomic Research (TIGR) developing genome assembly algorithms. Education: Ph.D., Computer Science, Johns Hopkins University, 2000. Research Interests: Bioinformatics, genomics, metagenomics, computational geometry, software testing. His lab develops tools for analyzing microbial communities and has pioneered methods for metagenomic assembly and analysis. Notable tools include the AMOS genome assembly toolkit. Recent Article Trends: Recent work emphasizes long-read sequencing, metagenomic profiling (e.g., TIPP3), and strain-level analysis (e.g., Strainy). He addresses challenges in scaling sequence-based searches and improving taxonomic resolution in large datasets. Awards: ACM Fellow (2019), ISCB Fellow (2022), UMD Excellence in Teaching Award (2015). Grants & Leadership: Co-leader of the Human Microbiome Project data analysis group. Active in diversity initiatives to promote inclusivity in computational fields. Labs/Teams: Pop Lab (pop-lab.org) focuses on computational methods for microbial genomics and metagenomics.
Hyunghoon Cho is an Assistant Professor at Yale School of Medicine in the Department of Biomedical Informatics & Data Science, with a secondary appointment in the Department of Computer Science. He received his PhD in Electrical Engineering and Computer Science from MIT (2019) and MS/BS in Computer Science from Stanford University (2013). His research focuses on computational challenges in biomedical data privacy, single-cell genomics, and network biology. Assistant Professor (Primary): Biomedical Informatics & Data Science Assistant Professor (Secondary): Computer Science Appointments: Yale School of Medicine | Broad Institute (Schmidt Fellow) Research Themes: Privacy-Enhancing Technologies for genomic and health data Scalable AI/ML tools for omics data analysis Structured biological modeling for system-level discovery His work includes secure GWAS, transcriptomic privacy assessment, and sfkit - a federated genomic analysis toolkit. He received the NIH Director's Early Independence Award and leads NSF-funded projects on confidential genome analytics. Awards: NIH Director's Early Independence Award Lab Members: Haris Smajlović (Postdoc), Vincent Angelo (CBB MS), Denis Loginov (Senior Software Engineer), Lucy Zheng (CBB PhD)
Marcus Smith is an Associate Professor in Law at the Charles Sturt University , where he teaches LAW222 Technology Law and directs the Bachelor of Laws program. He holds advanced degrees from the Australian National University (PhD, LLM) and the University of Cambridge (MPhil). His research spans technology law and regulation , focusing on genomic data governance biometric identification AI ethics blockchain policy cybersecurity surveillance law He leads the Contemporary Threats to Australian Security research group and serves as Chief Investigator on an NHMRC-funded project (MRF2015531) addressing genomic dataset governance. His recent work analyzes algorithmic bias in facial recognition AI in healthcare blockchain's regulatory challenges post-pandemic cybercrime surveillance ethics data security frameworks He actively supervises PhD and honours students in technology law and contributes to law reform through submissions to international bodies like the UN Human Rights Council .
Professor Daniel Segrè is a faculty member at Boston University, holding the title of Professor of Biology, Bioinformatics, and Biomedical Engineering. His research focuses on systems biology, microbial ecology, and metabolic engineering, with an emphasis on understanding complex biological networks and their applications in bioenergy and biomedicine. Segrè leads the Segre Lab ( segrelab.bu.edu ), where theoretical and computational approaches are applied to study metabolism, microbial interactions, and synthetic biology. Segrè earned his PhD from the Weizmann Institute of Science, Israel. His work bridges fundamental science and applied engineering, addressing topics such as microbial community dynamics, metabolic pathway design, and environmental microbiome applications. Research Interests: Systems biology of metabolism, evolution of biochemical networks, microbial interactions, bioinformatics, and environmental microbiome engineering. His lab develops computational models (e.g., COMETS) to simulate microbial ecosystems and design synthetic microbial communities for climate change mitigation and bioenergy production. Teaching: Courses include BE 777 (Computational Genomics), BF 821 (Bioinformatics Seminar), and BF 571 (Dynamics and Evolution of Biological Networks). These courses reflect his expertise in integrating computational methods with biological systems analysis.
Katja Hose is a Full Professor of Data Management at TU Wien's DBAI research unit, heading the Data Management and Knowledge-Driven AI Lab. She previously held a Poul Due Jensen Foundation Professorship at Aalborg University. Her research focuses on data and knowledge engineering, including graph databases, knowledge graphs, querying, analytics, and machine learning, with interdisciplinary applications in bioscience, healthcare, and environmental assessment. Education: PhD in Computer Science (Ilmenau University of Technology, 2009), Postdoc at Max Planck Institute for Informatics (2009–2012). Academic roles include Program Co-Chair for ISWC 2024 and EDBT 2023, and editorial board membership at VLDBJ and TGDK. She leads projects like TARGET (health virtual twins) and ARMADA (data management). Research Interests: Knowledge Graphs, Semantic Web, Big Data, Machine Learning, Data Integration, and Provenance Systems. Key contributions include SHACL shape extraction, conversational data analytics, and environmental knowledge graphs. Awards include the 2025 Distinguished Meta-Reviewer Award and 2024 Manfred Paul Award. Advising and Grants: Supervised students including E. Pürmayr (Diploma Thesis 2025). Active in EU projects (TARGET, ARMADA) and grant coordination. Labs/Teams: DMKI Lab at TU Wien, collaborating with interdisciplinary teams in healthcare and environmental science.
Britt Adamson is an Associate Professor in the Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University, where she serves as Director of the Undergraduate Program in Quantitative and Computational Biology. Her lab investigates molecular networks in human cells with focus on stress response mechanisms and genome editing technologies. She received her B.S. in Biology from the Massachusetts Institute of Technology (2005) and Ph.D. in Genetics and Genomics from Harvard University (2012), followed by postdoctoral training at UCSF under Jonathan Weissman supported by a Damon Runyon Cancer Research Foundation Fellowship. Adamson's research centers on how cells organize stress response networks during DNA damage and endoplasmic reticulum stress, developing CRISPR-based functional genomics and single-cell sequencing tools to map molecular behaviors. Her work bridges fundamental cell biology with therapeutic applications in genome editing. Analysis of her 15 most recent publications reveals dominant themes in precision genome editing (prime/base editing optimization) and systematic dissection of DNA repair pathways through combinatorial CRISPR screening. Her lab consistently integrates computational approaches with high-resolution experimental techniques to uncover context-dependent cellular behaviors. Her scientific recognitions include: Damon Runyon Cancer Research Foundation Postdoctoral Fellowship Princeton IP Accelerator Award (2025) STAT Who to Know: 10 Scientists leading a new generation of gene editors (2024) Adamson actively mentors eight graduate students (including alumni Ann Cirincione and Jun Hussmann) and two postdocs, with research funded through institutional awards and collaborative grants. Her lab's technological developments have enabled projects spanning virology, immunology, and developmental biology. The Adamson Lab operates within Princeton's Lewis-Sigler Institute for Integrative Genomics, fostering an interdisciplinary environment that merges cell biology, genomics, and computational science. Current projects focus on improving prime editing efficiency and understanding stress response adaptation in disease contexts.
Emma Pierson is an Assistant Professor of Computer Science at the University of California, Berkeley, affiliated with the Berkeley Artificial Intelligence Research Lab (BAIR) , Computational Precision Health , and the Center for Human-Compatible AI . She focuses on developing data science and machine learning methods to address issues in healthcare equity and social inequality . Her work includes studies on race adjustments in clinical algorithms, migration patterns, and leveraging LLMs for health equity. Education: Ph.D. in Computer Science from Stanford University (2020), Master’s in Statistics from the University of Oxford. Prior roles include Assistant Professor at Cornell Tech, Senior Researcher at Microsoft Research, and data scientist at 23andMe and Coursera. Research Interests: Her research spans fair clinical prediction , sparse autoencoders , health disparities , and algorithmic fairness . Notable projects include the MIGRATE dataset for granular migration analysis and studies on policing disparities. Awards: NSF CAREER Award, Rhodes Scholarship, Hertz Fellowship, MIT Technology Review 35 Innovators Under 35, and Samsung AI Researcher of the Year. She writes a statistics blog ( Obsession with Regression ) and contributes to media outlets like The New York Times and FiveThirtyEight . Labs/Teams: Leads the MIGRATE project, a collaboration to analyze fine-grained migration data. Engages in interdisciplinary work across AI, healthcare, and social science.
Itsik Pe'er is a Full Professor and Vice-Chair in the Department of Computer Science at Columbia University's Fu Foundation School of Engineering & Applied Science, and holds a joint appointment as Professor of Systems Biology at the Vagelos College of Physicians and Surgeons. His research focuses on computational methods in human genetics, including genetic variation analysis, disease association studies, and algorithm development for genomic data. He leads the Itsik Pe'er Lab of Computational Genomics, which develops tools like Xplorigin, Germline, and SEACells to address challenges in genomics and medical research. His work spans machine learning applications in healthcare, microbiome analysis, and cancer genomics. Notable contributions include studies on hypertensive disorders in pregnancy, bias correction in predictive models, and the development of non-Euclidean learning libraries like Manify. Pe'er has advised students including Vladimir Vacic, Anat Kreimer, and Arthi Ramachandran, and collaborates on grants addressing genetic epidemiology and computational biology. His lab's location is in the Computer Science Building at Columbia's Morningside Campus.
Professor Knut Reinert is a leading figure in algorithmic bioinformatics at the Free University of Berlin, where he holds a professorship in the Department of Mathematics and Computer Science. He also maintains a significant affiliation with the Max Planck Institute for Molecular Genetics in Berlin, where he leads the Efficient Algorithms for Omics Data group. His research spans both institutions through the Reinert Lab, which focuses on developing novel computational approaches for biological data analysis. Reinert's educational background includes a Diploma in Computer Science (1994) and a Doctorate (Dr. Ing./Ph.D., 1999, with honors) from the Max-Planck-Institut for Computer Science and Universität des Saarlandes in Saarbrücken. Prior to his professorship, he worked as a computer scientist under Prof. Gene Myers at Celera Genomics in Rockville, USA (1999-2002). His primary research interests center on algorithmic bioinformatics with specific focus on developing novel algorithms and data structures for biomedical mass data analysis. This includes creating mathematical models for genomic sequence analysis and algorithms for mass spectrometry data to detect differential protein expression between normal and diseased samples. His work bridges the gap between computational tool development and practical biological applications, with particular emphasis on NGS and proteomics data. The publications and projects led by Prof. Reinert demonstrate a consistent focus on advancing computational methods in bioinformatics. His research spans genomic sequence analysis, RNA research (particularly long non-coding RNAs), parallel computing applications, and GPU acceleration for biological data processing. The work shows increasing sophistication in handling large-scale biological datasets through innovative algorithmic approaches. Intel® Parallel Computing Center designation for his lab CUDA Research Center status DFG funding of 530 thousand Euros for RNA research de.NBI funding of 2 million Euros BMBF funded projects 'LIVE-DREAM' and 'EssBar' Prof. Reinert leads multiple significant research projects and has established strong collaborations with international partners including Texas A&M, Kings College London, Eberhardt-Karls Universität Tübingen, Robert-Koch-Institute, and various Turkish institutions. His lab receives funding from major organizations including DFG, BMBF, and Intel. The Reinert Lab maintains active teaching responsibilities at FU Berlin, offering courses at BSc, MSc, and PhD levels using both traditional and innovative learning concepts like e-learning and inverted classrooms. The Reinert Lab consists of two interconnected research groups that work closely with experimental biologists and medical researchers to develop practical computational solutions for real-world biological problems. The lab has established itself as a key player in the German and international bioinformatics community through its development of the widely-used SeqAn library and participation in national infrastructure initiatives.
Dr. Ahmet Acar is an Associate Professor at the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey. He leads the Cancer Precision Medicine and Drug Resistance Laboratory, focusing on understanding mechanisms of drug resistance in cancer. His research integrates experimental models, next-generation sequencing, and deep learning to address clinical challenges in cancer therapy. Dr. Acar holds a B.Sc. from METU's Biological Sciences department and a Ph.D. from the Cancer Research UK Manchester Institute. He completed postdoctoral training at the Institute of Cancer Research, London, and the University of Manchester. Research Interests: Drug resistance mechanisms, precision oncology, tumor microenvironment modeling, patient-derived organoids, computational pathology, and evolutionary cancer biology. His lab develops 2D/3D co-culture systems, PDO biobanks, and AI-driven histopathology tools to improve treatment strategies. Recent Work Trends: Recent publications emphasize tumor evolution modeling, matrix mechanics in drug resistance, and AI applications in histopathology. Collaborations with hospitals in Turkey and Europe support PDO biobank initiatives. His team explores evolutionary steering strategies to exploit collateral drug sensitivities. Labs/Teams: Precision Medicine and Drug Resistance Lab at METU focuses on interdisciplinary approaches combining wet-lab experiments with computational methods. Current projects include ex vivo tumor modeling and AI-driven diagnostic tools for oncology.
Kathryn Roeder is the UPMC University Professor of Statistics and Life Sciences at Carnegie Mellon University (CMU), affiliated with the Dietrich College of Humanities and Social Sciences and the Departments of Statistics & Data Science and Computational Biology. Her research focuses on developing statistical methods for genetic and genomic data, particularly in identifying autism risk genes and analyzing single-cell multi-omic data. She earned her Ph.D. in Statistics from Penn State University and has been at CMU since 1994, previously serving as Vice Provost for Faculty (2015–2019). Education: Ph.D. in Statistics, Penn State University (1988) B.S. in Wildlife Resources, University of Idaho (1982) Research Interests: Her work integrates modern statistical techniques (high-dimensional statistics, machine learning, networks) to study complex diseases like autism and schizophrenia. Recent efforts include tools for analyzing single-cell RNA-seq and proteomic data, such as UNICORN, DAWN, and SCEPTRE. Key Awards: COPSS Distinguished Achievement Award (2020) National Academy of Sciences Member (2019) COPSS Presidents’ Award (1997) AAAS Fellow (2020) Advising & Grants: She has advised over 20 Ph.D. students, many contributing to landmark studies in autism genetics. Her grants include NIH funding for projects like the Autism Sequencing Consortium. Current research teams focus on computational biology and statistical genetics. Labs & Collaborations: Her lab develops software tools (e.g., TADA, MIND) and collaborates with the Autism Sequencing Consortium and iPSYCH-BROAD Consortium on large-scale genomic studies.
Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.
Sushmita Roy is a Professor at the University of Wisconsin–Madison, affiliated with the Department of Computer Sciences and the College of Letters and Science. Her research focuses on developing computational methods in statistical machine learning to understand gene regulatory networks in living cells, particularly under environmental, developmental, disease, and evolutionary contexts. She explores bulk and single-cell genomic data integration to study processes like cell fate specification, host-microbe interactions, and diseases such as cancer and neurodevelopmental disorders. Her work emphasizes three key areas: inference of genome-scale transcriptional networks, evolutionary analysis of regulatory networks, and 3D genome organization dynamics. Roy’s lab collaborates across disciplines, leveraging genomic data from plant and mammalian systems. She has contributed to methodologies for analyzing chromatin accessibility, single-cell profiling, and network-based models of pathogen systems. Her affiliations include Wisconsin Institutes for Discovery, and she is a leader in computational biology and systems genomics research.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Antti Honkela is a Professor of Data Science at the University of Helsinki's Department of Computer Science, within the Faculty of Science. He also serves as the Coordinating Professor for the Privacy-preserving and Secure AI Research Programme at the Finnish Center for Artificial Intelligence (FCAI), and as Deputy Director of the Master's Programme in Data Science. His roles include membership in the Health and Social Data Permit Authority (Findata) and as an Action Editor for Transactions on Machine Learning Research. Honkela's research focuses on privacy-preserving machine learning, differential privacy, Bayesian methods, and their applications in computational biology and healthcare. He leads projects such as the European Lighthouse in Secure and Safe AI (ELSA) and the Data Literacy for Responsible Decision-making initiative. His work emphasizes developing robust frameworks for privacy-aware AI, including differentially private synthetic data and federated learning. Honkela has advised numerous PhD and Master's students, and his contributions span theoretical advancements and practical implementations, such as the D3p Python package for differentially private probabilistic programming. Key contributions include advancements in Bayesian inference from synthetic data, privacy accounting mechanisms, and computational methods for genomic epidemiology. His interdisciplinary approach bridges machine learning, statistics, and healthcare, addressing challenges in data privacy and secure AI deployment.
